This evening we watched CME drop -2.5% to a price of $211.76 per share. The large-cap Capital Markets company is now trading -7.3% below its average target price of $228.43. Analysts have set target prices ranging from $180.0 to $250.0 per share for CME, and have given the stock an average rating of buy.
The stock has a very low short interest at 1.0%, and a short ratio of 2.29. The company's insiders own 0.46% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 88.5% of CME's shares being owned by this investor type.
Institutions Invested in CME
|2023-06-30||Vanguard Group Inc||9%||33,309,592||$7,053,639,018|
|2023-06-30||JP Morgan Chase & Company||4%||15,984,554||$3,384,889,067|
|2023-06-30||State Street Corporation||4%||15,950,459||$3,377,669,110|
|2023-06-30||Capital International Investors||4%||13,996,964||$2,963,997,019|
|2023-06-30||Capital World Investors||4%||13,192,611||$2,793,667,232|
|2023-09-30||Capital Research Global Investors||2%||9,004,219||$1,906,733,365|
|2023-09-30||Geode Capital Management, LLC||2%||7,391,000||$1,565,118,119|
|2023-09-30||Bank Of New York Mellon Corporation||2%||7,091,141||$1,501,619,979|
|2023-09-30||Parnassus Investments, LLC||2%||5,643,801||$1,195,131,268|
Besides an analyst consensus of some upside potential, other market factors point to there being mixed market sentiment on CME.